During the past decade, Central Miami Medical Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Miami Medical Institute" are "Treatment Resistant Depression" (2 trials), "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials), "Obsessive Compulsive Disorder" (1 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "Central Miami Medical Institute" in a lesser frequency.

Most popular intervention types in "Central Miami Medical Institute" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Masupirdine 100 mg" (1 trials), "Masupirdine 50 mg" (1 trials), "Troriluzole" (1 trials) and "Troriluzole (BHV-4157)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Miami Medical Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Central Miami Medical Institute". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Central Miami Medical Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Miami Medical Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".